Abstract:Backgroud/Aims: The aim of this study was to investigate the potential renoprotective effect of rapamycin on the autophagy of podocytes treated with the supernatant of mesangial cells cultured with aggregated IgA1 (aIgA1) from immunoglobulin A nephropathy (IgAN) patients.METHODS:Monomeric IgA1 (mIgA1) was isolated from the serum of IgAN patients or healthy volunteers, and then transformed to aIgA1 by heating. Subsequently, the aIgA1-mesangial cell supernatant was prepared by collecting the medium of mouse mesangial cells (MSC1097) cultured with aIgA1 (100 mg/L) from different IgAN patients or healthy volunteers for 48 h. Subsequently mouse podocytes (MPC5) were exposed to the supernatant of the aIgA1-mesangial cells for 24 h, using 100 mg/L aIgA1 from healthy volunteers as the control group or 100 mg/L aIgA1 from IgAN patients as the IgANs group, in RPMI 1640 medium. The MPC5 cells in the IgANs+Rap group were cultured with rapamycin (10 nmol/L) and the supernatant of MSC-1097 cells cultured with aIgA1 from IgAN patients in RPMI 1640 medium. Autophagy was assessed by western blot analysis (LC3, p62), electron microscopy, and immunofluorescence staining (LC3, p62, and CD63). The apoptosis of podocytes was evaluated by flow cytometry, and the expression of apoptosis-associated proteins cleaved-caspase-3 and caspase-3 were determined by western blot analysis.RESULTS:Deficient autophagy, which was evident by decreased LC3-II and CD63 levels, caused accumulation of p62, and fewer autophagosomes were observed in the MPC5 cells cultured with the IgAN supernatant, along with stronger expression of cleaved caspase-3 and a higher apoptosis rate. Inhibition of autophagy was alleviated in the IgANs+Rap group. The LC3-II/LC3-I ratio increased by almost 30%, the accumulated p62 amount was reduced by 50%, and the number of autophagosomes per podocyte increased to about 7 times that of the IgAN groups. These results were confirmed by immunofluorescence staining. In addition, the apoptosis rate of MPC5 cells decreased from 19.88% in the IgAN group to 16.78% in the IgANs+Rap group, which was accompanied by a weaker expression level of cleaved caspase-3.CONCLUSIONS:Rapamycin can reduce the apoptosis of podocytes by inducing autophagy in IgAN.

Rapamycin increased inducible efficiency of iPSCs through activating autophagy

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes under a Stimulated Condition of Immunoglobulin A Nephropathy

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and Mtor/ P70S6K/4EBP1 Signaling.

Improvement in Mouse iPSC Induction by Rab32 Reveals the Importance of Lipid Metabolism during Reprogramming

Atg5-independent Autophagy Regulates Mitochondrial Clearance and is Essential for Ipsc Reprogramming

iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.

Rapamycin Inhibits Senescence and Improves Immunomodulatory Function of Mesenchymal Stem Cells Through IL-8 and TGF-β Signaling

Rapamycin Enhances Long-Term Hematopoietic Reconstitution Of Ex Vivo Expanded Mouse Hematopoietic Stem Cells By Inhibiting Senescence

Rapamycin Relieves Lentiviral Vector Transduction Resistance in Human and Mouse Hematopoietic Stem Cells.

Rapamycin Mediated Caspase 9 Homodimerization to Safeguard Human Pluripotent Stem Cell Therapy

Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy.

Rapamycin Improves Palmitate-Induced ER Stress/nf Κ B Pathways Associated with Stimulating Autophagy in Adipocytes.

Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in A Rat Model of Iga Nephropathy

An Elaborate Regulation of Mammalian Target of Rapamycin Activity is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors

Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway.

Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo.

Effects of rapamycin on DC-SIGN expression and biological functions in DC.

Continuous Passages Accelerate the Reprogramming of Mouse Induced Pluripotent Stem Cells

Rapamycin Enhances Mitophagy and Attenuates Apoptosis after Spinal Ischemia-Reperfusion Injury.

Administration of Rapamycin in Vivo and in Vitro Prolonged Allograft Survival Associated with Itregs